You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2014
|
| DOI | 10.1002/14651858.cd010340.pub2 |
| Pubmed ID | |
| Authors |
Arturo J Martí‐Carvajal, Vidhu Anand, Andrés Felipe Cardona, Ivan Solà |
| Abstract |
Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic, not malignant, disease of the hematopoietic stem cells, associated with significant morbidity and mortality. It is a rare disease with an estimated incidence of 1.3 new cases per one million individuals per year. The treatment of PNH has been largely empirical and symptomatic, with blood transfusions, anticoagulation, and supplementation with folic acid or iron. Eculizumab, a biological agent that inhibits complement cascade, was developed for preventing hemolytic anemia and severe thrombotic episodes. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 33% |
| Venezuela, Bolivarian Republic of | 1 | 8% |
| United States | 1 | 8% |
| Unknown | 6 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 7 | 58% |
| Members of the public | 5 | 42% |
Mendeley readers
The data shown below were compiled from readership statistics for 240 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 240 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 43 | 18% |
| Researcher | 25 | 10% |
| Student > Bachelor | 22 | 9% |
| Student > Ph. D. Student | 18 | 8% |
| Student > Doctoral Student | 18 | 8% |
| Other | 37 | 15% |
| Unknown | 77 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 79 | 33% |
| Nursing and Health Professions | 24 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Psychology | 9 | 4% |
| Biochemistry, Genetics and Molecular Biology | 8 | 3% |
| Other | 32 | 13% |
| Unknown | 79 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 April 2023.
All research outputs
#1,953,187
of 25,773,273 outputs
Outputs from Cochrane database of systematic reviews
#4,149
of 13,139 outputs
Outputs of similar age
#21,998
of 275,396 outputs
Outputs of similar age from Cochrane database of systematic reviews
#92
of 250 outputs
Altmetric has tracked 25,773,273 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,139 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 275,396 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 250 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.